GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (STU:154) » Definitions » Net Income Including Noncontrolling Interests

InMode (STU:154) Net Income Including Noncontrolling Interests : €140.5 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is InMode Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

InMode's Net Income Including Noncontrolling Interests for the three months ended in Sep. 2024 was €45.9 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 was €140.5 Mil.

InMode Net Income Including Noncontrolling Interests Historical Data

The historical data trend for InMode's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMode Net Income Including Noncontrolling Interests Chart

InMode Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial 55.04 61.67 146.09 152.48 181.49

InMode Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.59 50.59 21.80 22.13 45.94

InMode Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €140.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InMode Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of InMode's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

InMode Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (STU:154) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
NVCR PACB SSII PRCT ATEC TMDX UFPT TNDM AHCO AVNS ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
INMD:USA 154:Germany
Address
Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, ISR, 2069206
Website
https://www.inmodemd.com
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

InMode Headlines

No Headlines